By

The Ebola virus has shown us some viability and survivability in the recent past as the World Health Organization (WHO) reported on studies that showed that men who recovered from Ebola virus disease...

By

A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults. Better understanding of how adults develop RSV infection and immune...

Volunteer for a Hookworm Infection Study at the George Washington Medical Faculty Associates We are looking for healthy D.C.-area adults 18-45 years of age who are willing to participate in a research...

By

With school starting, or already started in many areas of the country, a Southern Illinois University researcher in a presentation at  the 250th National Meeting & Exposition of the American Chemical...

By

A novel synthetic DNA vaccine can, for the first time, induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species, reported researchers from the Perelman...

By

When a fever strikes in a developing area, the immediate concern may be: Is it the common flu or something much worse that requires quarantine? To facilitate diagnosis in remote, low-resource settings,...

Reporting in the prestigious journal Science this week, researchers from Stanford University have expanded on their previous work to show that yeast engineered with biotechnological methods can produce...

By

Working as part of an international team in North America and West Africa, a researcher at The Scripps Research Institute (TSRI) has published new findings showing the ancient roots of the deadly Lassa...

By

Between one-third and one-half of individuals in the United States who were infected with HIV around the time of birth may not have sufficient immunity to ward off measles, mumps, and rubella—even though...

By

Since the chickenpox vaccine became available in the U.S. in 1995, there has been a large reduction in chickenpox cases. Hospitalizations and outpatient visits for chickenpox have continued their decline...